Robert Phillips

Partner

I partner with life science and technology companies to help them grow and succeed, by guiding them through the process of accessing capital markets, raising funds, achieving strategic transactions and complying with corporate governance and securities laws.

+1 415 693 2020
rphillips@cooley.com

Rob Phillips has extensive experience advising public and private companies on general corporate issues, including corporate finance, securities laws compliance, corporate governance, debt exchanges and complex restructurings and M&A. He also advises US and non-US issuers and investment banks in capital markets offerings, including initial public offerings, follow-ons, convertible debt and high yield debt offerings. In addition to being a corporate partner, Rob is a registered foreign lawyer in Cooley HK, a registered foreign law firm in Hong Kong, which practices in association with CYL & Partners, a firm of Hong Kong solicitors, which includes Will Cai and Pang Lee, who are also partners in Cooley LLP.

Download full bio

Experience

  • Harpoon Therapeutics - $76 Million IPO 

  • Aduro Completes $137 Million IPO 

  • Kezar Life Sciences – $86 Million IPO 

  • Jazz Pharmaceuticals – $575 Million Exchangeable Senior Note Offering 

  • Semiconductor Developer Aquantia Closes $71 Million IPO 

  • View all

Education

  • Georgetown University Law Center
    JD, 1999

  • Georgetown University
    BSFS, cum laude, 1994


Admissions & Credentials

California

Contact

+1 415 693 2020 office
rphillips@cooley.com

101 California Street
5th Floor
San Francisco, CA 94111-5800